Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer

Overview of attention for article published in CPT: Pharmacometrics & Systems Pharmacology, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#39 of 805)
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 1 blog post.

#MathOnco Issue 64: physical sciences in oncology; heterogeneity; games margin:10px 0; padding:0; } table{ border-c…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.